Palvella Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PVLA and other ETFs, options, and stocks.About PVLA
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. It develops a pipeline of treatments for rare genetic skin diseases using its patented QTORIN platform.
PVLA Key Statistics
Stock Snapshot
As of today, Palvella Therapeutics(PVLA) shares are valued at $85.43. The company's market cap stands at 1.05B, with a P/E ratio of -6.50.
During the trading session on 2026-02-13, Palvella Therapeutics(PVLA) shares reached a daily high of $86.10 and a low of $81.76. At a current price of $85.43, the stock is +4.5% higher than the low and still -0.8% under the high.
Trading volume for Palvella Therapeutics(PVLA) stock has reached 12.57K, versus its average volume of 347.06K.
The stock's 52-week range extends from a low of $16.65 to a high of $114.69.
The stock's 52-week range extends from a low of $16.65 to a high of $114.69.
Analyst ratings
100%
of 16 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.